In another study, naringenin was found to activate the Nrf2 signaling pathway and inhibit the NF-κB signaling pathway in DCM rat models, suggesting that naringenin may affect multiple signaling pathways involved in the formation of DCM simultaneously [95]. Here, NFKB1 is linked to familial dilated cardiomyopathy.